Press release
Dry Age Macular Degeneration Pipeline Insights 2024: Therapies, Clinical Trials, Therapies and Key Companies involved by DelveInsight |Janssen R&D, Belite Bio, Katairo, Cognition Therapeutics
"Dry Age Macular Degeneration Pipeline Insight, 2024 [https://www.delveinsight.com/sample-request/dry-age-macular-degeneration-pipeline-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the Dry Age Macular Degeneration Market.
The Dry Age Macular Degeneration Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the drug, including the mechanism of action of the drug, clinical studies, NDA approvals (if any), and product development activities comprising the technology, collaborations, mergers acquisition, funding, designations, and other product-related details.
Some of the key takeaways from the Dry Age Macular Degeneration Pipeline Report:
*
Companies across the globe are diligently working toward developing novel Dry Age Macular Degeneration treatment therapies with a considerable amount of success over the years.
*
Dry Age Macular Degeneration companies working in the treatment market are Eyevensys, SanBio, Nanoscope Therapeutics, Luxa Biotechnology, Regenerative Patch Technologies, Allegro Ophthalmics, Gyroscope Therapeutics, IVERIC bio, Alkeus Pharmaceuticals, Gemini Therapeutics, Eyestem, OliX Pharmaceuticals, and others, are developing therapies for the Dry Age Macular Degeneration treatment
*
Emerging Dry Age Macular Degeneration therapies in the different phases of clinical trials are- EYS809, SB-623, MCO-020, RPESC RPE 4W, CPCB-RPE1, Risuteganib, GT005, Zimura, ALK-001, GEM103, Eyecyte RPE, OLX301A, EYS809, and others are expected to have a significant impact on the Dry Age Macular Degeneration market in the coming years.
*
In June 2024, Stealth BioTherapeutics has enrolled the first participant in the Phase III ReNEW clinical trial, part of a clinical program to evaluate elamipretide for the treatment of dry age-related macular degeneration (AMD). This randomized, double-masked, placebo-controlled trial will assess the efficacy, safety, and pharmacokinetics of once-daily subcutaneous injections of elamipretide.
Dry Age Macular Degeneration Overview
Dry age-related macular degeneration (AMD) involves a gradual breakdown of macular cells over an extended period. This occurs as retinal cells decline without renewal. It's important to note that the term 'dry' doesn't imply dry eyes but rather distinguishes it from wet AMD.
Get a Free Sample PDF Report to know more about Dry Age Macular Degeneration Pipeline Therapeutic Assessment-
https://www.delveinsight.com/report-store/dry-age-macular-degeneration-pipeline-insight [https://www.delveinsight.com/report-store/dry-age-macular-degeneration-pipeline-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]
Emerging Dry Age Macular Degeneration Drugs Under Different Phases of Clinical Development Include:
*
EYS809: Eyevensys
*
SB-623: SanBio
*
MCO-020: Nanoscope Therapeutics
*
RPESC RPE 4W : Luxa Biotechnology
*
CPCB-RPE1: Regenerative Patch Technologies
*
Risuteganib: Allegro Ophthalmics
*
GT005: Gyroscope Therapeutics
*
Zimura: IVERIC bio
*
ALK-001: Alkeus Pharmaceuticals
*
GEM103: Gemini Therapeutics
*
Eyecyte RPE: Eyestem
*
OLX301A: OliX Pharmaceuticals
*
EYS809: Eyevensys
Dry Age Macular Degeneration Route of Administration
Dry Age Macular Degeneration pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration. Products have been categorized under various ROAs, such as
*
Intra-articular
*
Intraocular
*
Intrathecal
*
Intravenous
*
Ophthalmic
*
Oral
*
Parenteral
*
Subcutaneous
*
Topical
*
Transdermal
Dry Age Macular Degeneration Molecule Type
Dry Age Macular Degeneration Products have been categorized under various Molecule types, such as
*
Oligonucleotide
*
Peptide
*
Small molecule
Dry Age Macular Degeneration Pipeline Therapeutics Assessment
*
Dry Age Macular Degeneration Assessment by Product Type
*
Dry Age Macular Degeneration By Stage and Product Type
*
Dry Age Macular Degeneration Assessment by Route of Administration
*
Dry Age Macular Degeneration By Stage and Route of Administration
*
Dry Age Macular Degeneration Assessment by Molecule Type
*
Dry Age Macular Degeneration by Stage and Molecule Type
DelveInsight's Dry Age Macular Degeneration Report covers around 64+ products under different phases of clinical development like
*
Late-stage products (Phase III)
*
Mid-stage products (Phase II)
*
Early-stage product (Phase I)
*
Pre-clinical and Discovery stage candidates
*
Discontinued & Inactive candidates
*
Route of Administration
Further Dry Age Macular Degeneration product details are provided in the report. Download the Dry Age Macular Degeneration pipeline report to learn more about the emerging Dry Age Macular Degeneration therapies [https://www.delveinsight.com/sample-request/dry-age-macular-degeneration-pipeline-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]
Some of the key companies in the Dry Age Macular Degeneration Therapeutics Market include:
Key companies developing therapies for Dry Age Macular Degeneration are - Janssen Research & Development, Belite Bio, Katairo, Cognition Therapeutics, Eye Co Pty Ltd, Applied Genetic Technologies Corporation (AGTC), Aviceda Therapeutics, Kodiak Sciences, Ascentage Pharma, OliX Pharmaceutical, Nanoscope Therapeutics, Inc., Biophytis, Eyestem, Eyevensys, SanBio, Beta Therapeutics, MacRegen, Amarna Therapeutics, MeiraGTx, Cognition Therapeutics, Ocugen, Catalyst Biosciences, Endogena Therapeutics, Oculogenex, Clover Therapeutics, and others.
Dry Age Macular Degeneration Pipeline Analysis:
The Dry Age Macular Degeneration pipeline report provides insights into
*
The report provides detailed insights about companies that are developing therapies for the treatment of Dry Age Macular Degeneration with aggregate therapies developed by each company for the same.
*
It accesses the Different therapeutic candidates segmented into early-stage, mid-stage, and late-stage of development for Dry Age Macular Degeneration Treatment.
*
Dry Age Macular Degeneration key companies are involved in targeted therapeutics development with respective active and inactive (dormant or discontinued) projects.
*
Dry Age Macular Degeneration Drugs under development based on the stage of development, route of administration, target receptor, monotherapy or combination therapy, a different mechanism of action, and molecular type.
*
Detailed analysis of collaborations (company-company collaborations and company-academia collaborations), licensing agreement and financing details for future advancement of the Dry Age Macular Degeneration market.
The report is built using data and information traced from the researcher's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations, and featured press releases from company/university websites and industry-specific third-party sources, etc.
Download Sample PDF Report to know more about Dry Age Macular Degeneration drugs and therapies [https://www.delveinsight.com/sample-request/dry-age-macular-degeneration-pipeline-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]
Dry Age Macular Degeneration Pipeline Market Drivers
*
Growing geriatric population and rising prevalence of AMD, robust pipeline for dry AMD treatment are some of the important factors that are fueling the Dry Age Macular Degeneration Market.
Dry Age Macular Degeneration Pipeline Market Barriers
*
However, lack of awareness about dry AMD, lengthy and expensive clinical trials, lack of early detection and other factors are creating obstacles in the Dry Age Macular Degeneration Market growth.
Scope of Dry Age Macular Degeneration Pipeline Drug Insight
*
Coverage: Global
*
Key Dry Age Macular Degeneration Companies: Eyevensys, SanBio, Nanoscope Therapeutics, Luxa Biotechnology, Regenerative Patch Technologies, Allegro Ophthalmics, Gyroscope Therapeutics, IVERIC bio, Alkeus Pharmaceuticals, Gemini Therapeutics, Eyestem, OliX Pharmaceuticals, and others
*
Key Dry Age Macular Degeneration Therapies: EYS809, SB-623, MCO-020, RPESC RPE 4W, CPCB-RPE1, Risuteganib, GT005, Zimura, ALK-001, GEM103, Eyecyte RPE, OLX301A, EYS809, and others
*
Dry Age Macular Degeneration Therapeutic Assessment: Dry Age Macular Degeneration current marketed and Dry Age Macular Degeneration emerging therapies
*
Dry Age Macular Degeneration Market Dynamics: Dry Age Macular Degeneration market drivers and Dry Age Macular Degeneration market barriers
Request for Sample PDF Report for Dry Age Macular Degeneration Pipeline Assessment and clinical trials [https://www.delveinsight.com/sample-request/dry-age-macular-degeneration-pipeline-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]
Table of Contents
1. Dry Age Macular Degeneration Report Introduction
2. Dry Age Macular Degeneration Executive Summary
3. Dry Age Macular Degeneration Overview
4. Dry Age Macular Degeneration- Analytical Perspective In-depth Commercial Assessment
5. Dry Age Macular Degeneration Pipeline Therapeutics
6. Dry Age Macular Degeneration Late Stage Products (Phase II/III)
7. Dry Age Macular Degeneration Mid Stage Products (Phase II)
8. Dry Age Macular Degeneration Early Stage Products (Phase I)
9. Dry Age Macular Degeneration Preclinical Stage Products
10. Dry Age Macular Degeneration Therapeutics Assessment
11. Dry Age Macular Degeneration Inactive Products
12. Company-University Collaborations (Licensing/Partnering) Analysis
13. Dry Age Macular Degeneration Key Companies
14. Dry Age Macular Degeneration Key Products
15. Dry Age Macular Degeneration Unmet Needs
16 . Dry Age Macular Degeneration Market Drivers and Barriers
17. Dry Age Macular Degeneration Future Perspectives and Conclusion
18. Dry Age Macular Degeneration Analyst Views
19. Appendix
20. About DelveInsight
About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance. It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate business growth and overcome challenges with a practical approach.
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Gaurav Bora
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=dry-age-macular-degeneration-pipeline-insights-2024-therapies-clinical-trials-therapies-and-key-companies-involved-by-delveinsight-janssen-rd-belite-bio-katairo-cognition-therapeutics]
Phone: +14699457679
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Dry Age Macular Degeneration Pipeline Insights 2024: Therapies, Clinical Trials, Therapies and Key Companies involved by DelveInsight |Janssen R&D, Belite Bio, Katairo, Cognition Therapeutics here
News-ID: 3814644 • Views: …
More Releases from ABNewswire
5-Star Towing OKC Launches New Digital Hub to Redefine Oklahoma City Roadside As …
In a move to modernize the often-stressful experience of vehicle breakdowns, 5-Star Towing OKC has announced the launch of its newly redesigned website. The platform is set to become the new standard for Oklahoma City towing, offering unprecedented digital tools that put help directly into the hands of drivers.
The new website, found at www.247okctowing.com [http://www.247okctowing.com/], functions as a digital command center. It allows motorists to request a tow, jump-start, roadside…
Why Choose Logo Software for The Business Growth
Logo Software provides comprehensive and integrated enterprise solutions designed to support sustainable business growth. By combining finance, supply chain, human resources, production, and sales management into a unified ecosystem, Logo Software [https://www.logo.com.tr/en] helps organizations eliminate data silos and improve operational transparency. Its scalable and modular infrastructure makes it suitable for startups, SMEs, and large enterprises alike, allowing businesses to expand their systems as they grow without disrupting operations.
Top Advantages of…
Artallin Redefines Original Hand-Painted Oil Paintings Online: The Best Alternat …
NEW YORK - Feb. 26, 2026 - For homeowners and interior designers searching for original hand-painted oil paintings online, the market has long been dominated by mass-produced prints or inaccessible gallery prices. Today, Artallin officially launches its new Direct-to-Consumer (DTC) platform in the United States, offering a trusted space to buy art directly from independent artists. Positioned as the ultimate real oil painting on canvas, not print solution, Artallin [https://artallin.com/]…
The Veekys RGBIC Frunk Light Pro is the First Must-Have Mod for the Tesla Model …
As the refreshed 2025 Tesla Model Y (project "Juniper") hits the streets, early adopters are already hunting for ways to personalize their new rides. While Tesla has undoubtedly refined the vehicle's interior aesthetics, one glaring omission remains: the front trunk (frunk) is still notoriously dark at night.
Enter Veekys [https://veekys.com/], a premium EV accessory brand that has quickly become a favorite among Tesla enthusiasts. Their latest release-the Frunk Light Pro for…
More Releases for Dry
Dry Fruits Mart Expands Its Premium Dry Fruits and Organic Products Line Across …
Dry Fruits Mart has officially announced the nationwide expansion of its premium dry fruits and organic product line across Pakistan, responding to the growing demand for high-quality, natural, and nutrient-rich food products. The expansion reflects the brand's continued growth and commitment to serving customers who prioritize healthier lifestyle choices.
More information about the company and its complete product portfolio is available at: https://dryfruitsmart.pk/
As part of this development, the company has…
Rising Prevalence Of Dry Eye Conditions Boosts Growth In Dry Eye Products Market …
The Dry Eye Products Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Expected Dry Eye Products Market Size During the Forecast Period?
In recent years, there has been a significant expansion in the market size of dry eye products. The market is projected…
Dry Powder Inhalers Market - Breathe Freely: Dry Powder Inhalers Empowering Asth …
Newark, New Castle, USA: The "Dry Powder Inhalers Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors.
Dry Powder Inhalers Market: https://www.growthplusreports.com/report/dry-powder-inhalers-market/8762
This latest report researches the industry structure,…
Dry Eye Market - Advancing Eye Wellness: Dry Eye Solutions Revolutionizing Relie …
Newark, New Castle, USA - new report, titled Dry Eye Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Dry Eye market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Dry Eye market. The report offers an overview of the market, which…
Dry Lubricants Market Size to Hit $ 813.78 Million by 2028 | Dry Lubricants Indu …
According to our experience research team, Dry Lubricants Market was valued at USD 755.42 Million in 2021, and the global Dry Lubricants industry is projected to reach a value of USD 813.78 Million by 2028, at a CAGR of 1.2% during the forecast period 2022-2028
The report is focused on gaining various Dry Lubricants market trends, dynamics, growth drivers, opportunities, weaknesses, strengths, and threats restraining the market growth. Further, the global…
Dry Ice Market In-Depth Analysis | Key Participants Dry Ice Corp., Dry Ice UK Lt …
Demand for dry ice is expected to magnify with the development of dry ice machines industry across the globe. Manufacturers in large multinational organizations and private firms have been contributing prominently in the revenue growth of dry ice market. Dry ice being a cost-effective product is expected to bolster its demand across various applications in the near future. Rising number of fire accidents leads to increasing demand for dry ice,…
